Musculoskeletal Health Systematic Review: Clinical and Pharmacological, Organizational and Legal, Administration and Pharmaceutical Management Aspects
DOI:
https://doi.org/10.53933/sspmpm.v4i2.134Keywords:
evidence-based medicine, evidence-based pharmacy, ICD-11, musculoskeletal health, musculoskeletal disorders, administration, management, pharmacotherapyAbstract
This article examines current aspects of musculoskeletal health and pharmacotherapy of disorders of the human musculoskeletal system. An objective review of disorders of the musculoskeletal system was conducted in the areas of administration, clinical and pharmacological, organizational and legal, pharmaceutical management. The results of the systematic review show that the availability of diagnoses in the section "Orthopedics and traumatology" on the platform of the state expert center of the Ministry of Health of Ukraine is limited. It is necessary and urgent to expand the scientific base for practicing doctors. The study confirmed the importance of using new clinical protocols in medical and pharmaceutical practice for the implementation of evidence-based medicine and evidence-based pharmacy in Ukraine. Gradual improvement of medical and pharmaceutical practice allows to increase the quality, efficiency, safety, availability of pharmacotherapy for patients with disorders of the musculoskeletal system. The paper examines guidelines developed on the basis of health evidence provided by Duodecim Medical Publications. The study shows the availability of a wide range of treatment methods and helps to determine optimal therapy strategies in the field of orthopedics. It was found that non-steroidal anti-inflammatory drugs and analgesics are more often prescribed for the pharmacotherapy of disorders of the musculoskeletal system, which emphasizes the perspective of further clinical and pharmacological, organizational and legal researches in the pharmaceutical development and management of new drugs.
References
Musculoskeletal health. WHO. 14 July 2022. URL: https://www.who.int/news-room/fact-sheets/detail/musculoskeletal-conditions
Hartvigsen J., Hancock M., Kongsted A. et al. Lancet Low Back Pain Series Working Group. What low back pain is and why we need to pay attention. Lancet. 2018. No.391. Р.2356–2367. doi.org/10.1016/S0140-6736(18)30480-X. URL: (www.umj.com.ua/uk/novyna-205707-bil-u-popereku-oglyad-danih-ta-osnovni-rekomendatsiyi-z-reabilitatsiyi) DOI: https://doi.org/10.1016/S0140-6736(18)30480-X
Zhang S., Xing M., Li B. Recent advances in musculoskeletal local drug delivery. Acta Biomaterialia. 2019. Vol.93. No.1. P.135-151. URL: https://www.sciencedirect.com/science/article/abs/pii/S1742706119300637
De Gray L.E., Seth B. Drugs used to treat joint and muscle disease. Anaesthesia & Intensive Care Medicine. 2021. Vol. 22. Iss. 1. P. 70-76. URL: https://www.sciencedirect.com/science/article/abs/pii/S1472029920302320. DOI: https://doi.org/10.1016/j.mpaic.2020.11.001
Williams A., Camper S., Wiggers D. et al. Musculoskeletal disorders may increase the risk of chronic disease: a systematic review and meta-analysis of cohort studies. BMC Medicine. 2018. Vol.16. No.1. P.167. URL: https://pubmed.ncbi.nlm.nih.gov/30249247/ DOI: https://doi.org/10.1186/s12916-018-1151-2
Shapovalova V. Post-Traumatic Stress Disorder: administration, clinical and pharmacological, organizational and legal, pharmaceutical management, recent case studies. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-8. URL: https://doi.org/10.53933/sspmpm.v4i1.123 DOI: https://doi.org/10.53933/sspmpm.v4i1.123
Shapovalova V. The ICD-11 for the twenty-first century: the first view from the organizational, legal, clinical and pharmacological aspects. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 1. Р. 1-13. URL: https://doi.org/10.53933/sspmpm.v2i1.37 DOI: https://doi.org/10.53933/sspmpm.v2i1.37
Rehabilitation is not a service for the few. URL: https://vizhub.healthdata.org/rehabilitation/
International Classification of Diseases 11th revision (ICD-11). WHO. URL: https://icd.who.int/en
State Expert Center of the Ministry of Health of Ukraine. URL: https://www.dec.gov.ua/mtd/home/
Order of the Ministry of Health of Ukraine dated December 29, 2016 No. 1422 "On Amendments to the Order of the Ministry of Health of Ukraine dated September 28, 2012 No. 751." Verkhovna Rada of Ukraine. URL: https://zakon.rada.gov.ua/laws/show/z0530-17#Text
Guidelines based on evidence-based medicine. Created by DUODECIM Medical Publications, Ltd. Ministry of Health of Ukraine. URL: https://guidelines.moz.gov.ua/documents
Musculoskeletal Pain. Cleveland Clinic. 2024. URL: https://my.clevelandclinic.org/health/diseases/14526-musculoskeletal-pain
Shapovalova V. Forensic and pharmaceutical risks in the organization of pharmacotherapy of covid, post-covid and long-covid disorders. COVID-19 and vaccination practice standards. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1–24. DOI: https://doi.org/10.53933/sspmpm.v2i4.69. DOI: https://doi.org/10.53933/sspmpm.v2i4.69
Osyntseva A. Tuberculosis: pharmacognosy, medicinal plant raw materials, medicinal plants, phytotherapy. SSP Modern Pharmacy and Medicine. 2024. Vol.4. No.1. P.1-10. URL: https://doi.org/10.53933/sspmpm.v4i1.130 DOI: https://doi.org/10.53933/sspmpm.v4i1.130
Vovk D., Puhach O., Bachynska L. et al. The Role of the general practitioner-family doctor in the pharmacotherapy of Tuberculosis during the war. SSP Modern Pharmacy and Medicine. 2023. Vo.3. No.3. P.1-7. URL: https://doi.org/10.53933/sspmpm.v3i3.102 DOI: https://doi.org/10.53933/sspmpm.v3i3.102
Shapovalov (Jr.) V., Shapovalova V., Gudzenko A. et al. Organizational and legal analysis of the pharmaceutical provision for the most common diseases of society. International Journal of Pharmaceutical Sciences Review and Research. 2018. Vol.51. Nо.1. P. 118-124. URL: http://globalresearchonline.net/journalcontents/v51-1/18.pdf.
World Health Organization. URL: https://www.who.int/news-room/questions-and-answers/item/monkeypox
Hayduchok I.G., Shapovalova V.O., Ishcheikin K.E. et al. Pharmaeconomic approaches for pharmacotherapy of Rheumatoid arthritis. Likars’ka Sprava. 2021. Nо. 1-2. P.54-63. DOI: https://doi.org/10.31640/JVD.1-2.2021(11) DOI: https://doi.org/10.31640/JVD.1-2.2021(11)
Shapovalov V. Multidisciplinary study of medical errors in the system of legal relations between "Doctor-Patient-Pharmacist-Advocate" during the circulation of drugs. SSP Modern Pharmacy and Medicine. 2023. Vol. 3. No. 2. P. 1-11. URL: https://doi.org/10.53933/sspmpm.v3i2.88 DOI: https://doi.org/10.53933/sspmpm.v3i2.88
Gryzodub O., Shapovalov V. Quality systems in Pharmacy: multidisciplinary context of the State Pharmacopoeia of Ukraine. SSP Modern Law and Practice. 2023. Vol.3. No.1. P.1-23. DOI: https://doi.org/10.53933/sspmlp.v3i1.81 DOI: https://doi.org/10.53933/sspmlp.v3i1.81
Shapovalov V. Medical errors in health care institutions: an interdisciplinary study of the competences of specialists based on medical and pharmaceutical law. SSP Modern Law and Practice. 2023. Vol.3. No.4. P. 1-14. URL: https://doi.org/10.53933/sspmlp.v3i4.121 DOI: https://doi.org/10.53933/sspmlp.v3i4.121
Shapovalova V., Shapovalov V., Osyntseva A. et al. Organization of the pharmaceutical business, industrial pharmacy and forensic pharmacy concerning the competences of quality management during the circulation of medical products: GxP standards. Actual problems of medicine and pharmacy. 2022. Vol.3. No. 2. P. 1–20. DOI: https://doi.org/10.52914/apmp.v3i2.44
Shapovalov V., Veits O. Forensic and pharmaceutical, criminal and legal, social and economic study of the conditions, that cause bribery corruption in the system of legal relations "doctor-patient-investigator-lawyer". SSP Modern Law and Practice. 2022. Vol. 2. No. 3. P. 1-16. URL: https://doi.org/10.53933/sspmlp.v2i3.57 DOI: https://doi.org/10.53933/sspmlp.v2i3.57
Hayduchok I., Tukhar I., Shapovalov V. Chronic Pancreatitis, comorbid with alcohol addiction: epidemiology, causes, developmental features, symptoms and supportive pharmaceutical therapy. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 2. P. 1-13. URL: https://doi.org/10.53933/sspmpm.v2i2.46 DOI: https://doi.org/10.53933/sspmpm.v2i2.46
Osyntseva A. Polydrug addiction: multidisciplinary forensic and pharmaceutical, organizational and legal, and technological study of factors of formation and development. SSP Modern Pharmacy and Medicine. 2022. Vol. 2. No. 4. P. 1-14. URL: https://doi.org/10.53933/sspmpm.v2i4.72 DOI: https://doi.org/10.53933/sspmpm.v2i4.72
Shapovalova V.A., Stefanov A.V., Trakhtenberg I.M. et al. Pharmaceutical law in safe self-treatment: drugs dispensed without a doctor's prescription. 2nd ed. Kh.: FAKT, 2005. 800 p.
Shapovalova V.O., Mykhaĭlov V.S., Shapovalov V.V. [The characteristics of the development of cataleptic phenomena during the action of a new Ukrainian neuroleptica butyrophenone derivative--in experiments on mice]. Fiziol. Zh. 1999. Vol. 45. No.3. Р.114-117. URL: https://pubmed.ncbi.nlm.nih.gov/10439301/.
Shapovalova V.O., Shapovalov V.V. [Spasmophilia in children and the anticonvulsant properties of a new Ukrainian preparation containing a pyrimidine derivative]. Fiziol. Zh. 1998. Vol. 44. No.5-6. Р.102-105. URL: https://pubmed.ncbi.nlm.nih.gov/9866032/. DOI: https://doi.org/10.1049/ir:19980309
Shapovalova V.O., Chernykh V.P. [The physiological properties of the action of a new analgesic and antipyretic preparation]. Fiziol. Zh. 1997. Vol. 43. No.1-2. P. 117-121. URL: https://pubmed.ncbi.nlm.nih.gov/9221112/.
Shapovalova V.O. [Paracetamol pharmacokinetics in the blood plasma of sexually immature rabbits with the use of the new Paravit preparation]. Fiziol. Zh. 1995. Vol.41. No.5-6. P. 57-60. URL: https://pubmed.ncbi.nlm.nih.gov/9026394/.
Shapovalova V.O. [The effect of Val'kofen tablets for children on the function of the gastrointestinal tract and liver in an experiment]. Fiziol. Zh. 1995. Vol. 41. No. 5-6. Р. 111-116. URL: https://europepmc.org/article/med/9026383.
De Sire A., Marotta N., Lippi L. et al. Pharmacological treatment for acute traumatic musculoskeletal pain in athletes. Medicina (Kaunas). 2021. Vol. 57. No. 11. e1208. DOI: https://doi.org/10.3390/medicina57111208 DOI: https://doi.org/10.3390/medicina57111208
Cieza A., Causey K., Kamenov K. et al. Global estimates of the need for rehabilitation based on the Global Burden of Disease study 2019: a systematic analysis for the Global Burden of Disease Study 2019. The Lancet. 2019. Vol.396. No.10267. P.2006–2017. URL: https://pubmed.ncbi.nlm.nih.gov/33275908/ DOI: https://doi.org/10.1016/S0140-6736(20)32340-0
Zhang S., Xing M., Li B. Recent advances in musculoskeletal local drug delivery. Acta. Biomater. 2019. No.93. Р.135-151. DOI: https://doi.org/10.1016/j.actbio.2019.01.043 DOI: https://doi.org/10.1016/j.actbio.2019.01.043
Shapovalov V., Piontkovskyi V., Huzovatyi O. An Interdisciplinary approach to development of a new combined medicine for musculoskeletal disorders. SSP Modern Pharmacy and Medicine. 2023. Vol.3. No.4. P.1-17. URL: https://doi.org/10.53933/sspmpm.v3i4.115 DOI: https://doi.org/10.53933/sspmpm.v3i4.115
Shapovalov V., Osyntseva A., Shapovalov V. Organization of pharmaceutical business, drug technology, forensic and clinical pharmacy: multidisciplinary innovative nanotechnologies in the development and implementation of new medical products to medical and pharmaceutical practice. SSP Modern Pharmacy and Medicine. 2022. Vol.2. No.3. P.1-18. URL: https://doi.org/10.53933/sspmpm.v2i3.61 DOI: https://doi.org/10.53933/sspmpm.v3i1.83
Shapovalova V.A., Voloshin P.V., Stefanov A.V. et al. Drugs in neurology, psychiatry and narcology. Kh.: Fakt, 2003. 770 p.
Viltsanyuk A.A., Belyaev P.V., Osolodchenko T.P. et al. Nanocomposite drugs in complex treatment of purulent wounds. Nanotechnologies and nanomaterials in pharmacy and medicine: materials of the 5th All-Ukrainian scientific and practical internet conference with international participation (April 23, 2021, Kharkiv). Kharkiv: NFaU, 2021. P. 23-24.
Nanosystems, nanomaterials, nanotechnologies. National Academy of Sciences of Ukraine H. V. Kurdyumov Institute of Metallurgy. Kyiv: RVV IMF. T. 18, issue 1. Kyiv, 2020. 218 p.
Savchenko I.O. Nanochemistry and nanotechnology: a textbook. Kyiv National Taras Shevchenko University. Kyiv: Publishing and printing center “Kyiv University”, 2019. 448 p.
Santos A.M., Pereira S.P., Mezakasa A.V. Emodin-containing nanoparticles of mesoporous silica type MSM-41 - drug delivery systems. Theoretical and experimental chemistry. 2020. T.56. No. 3. P.164-171.
Fesenko O.M., Kovalchuk S.V., Nyshchyk R.A. Problems and prospects of nanotechnology development in Ukraine and the world. Marketing and innovation management. 2017. No. 1. P.170-179. URL: http://mmi.fem.sumdu.edu.ua/. DOI: https://doi.org/10.21272/mmi.2017.1-15
Pharmaceutical analysis of drugs. Under ed. of V.A. Shapovalova. Kh.: Rubikon. 1995. 398 p.
Moskalenko V.F., Lisovyi V.M., Chekman I.S. et al. Scientific foundations of nanomedicine, nanopharmacology and nanopharmacy. Visn. National honey. University named after O.O. Bogomolets. 2009. No. 2. P. 17–31.
Paton B., Moskalenko V.F., Chekman I.S. et al. Nanoscience and nanotechnology: technical, medical and social aspects. National Academy of Sciences of Ukraine. 2009. 2-9. No. 6: pp. 18–26.
Chekman I.S. Nanoscience: perspectives of scientific research. Science and innovation. 2009. No. 5(3). P. 89–93.
Shapovalov V.V. Forensic pharmacy: the use of targeted nanotherapy in drug patients (criminals) suffering from addictive health disorders. Ukrainian Bulletin of Psychoneurology. 2010. Vol. 18, issue 3. P. 62–64.
Shapovalov V.V. Forensic and evidence-based pharmacy: application of nanotechnological approaches in addictive health disorders in drug patients with deviant behavior through extracorporeal and intracorporeal methods of treatment. Ukrainian Bulletin of Psychoneurology. 2011. Vol. 19, issue 2 (appendix). P. 222–224.
Shapovalov V.V. Forensic and pharmaceutical study of drug addiction in Ukraine and modern approaches to its pharmacotherapy using nanotechnology. Ukrainian Bulletin of Psychoneurology. 2012. Vol. 20, issue 2 (appendix). P.107-111.
Shapovalov V.V. Organizational and legal aspects of the use of nanotechnologies in the circulation of psychoactive medicinal products. Ukrainian Bulletin of Psychoneurology. 2013. Vol. 21, issue 3. P.102–104.
Shapovalov V. Use of innovative technologies in pharmacotherapy with target nanotherapy on the principles of evidence-based medicine and pharmacy. Actual problem of medicine and pharmacy. 2020. Vol. 1 No. 1-2. URL: http://apmplmi.com.
Chekman I.S., Gorchakova N.O., Ozeychuk O.Yu. Nanomaterials and nanoparticles: classification. Scientific Bulletin of the Bohomolets National Medical University. 2009. No. 2. P. 188–201.
Chekman I.S., Serdyuk A.M., Kundiyev, etc. Nanotoxicology: directions of research (review). Environment and health. 2009. No. 48 (1). P. 3–7.
Yudi D., Xudong Z., Haibin S. еt. аl. Аpplication of the nano-drug delivery system in treatment of cardiovascular diseases. Frontiersin. 31.01.2020. URL: https://www.frontiersin.org/articles/10.3389/fbioe.2019.00489/full.
Improving the system of drug circulation during pharmacotherapy on the basis of evidence-based and forensic pharmacy, organization, technology, biopharmacy and pharmaceutical law. Registration card of the approvement of the scientific work. State registration No.: 0120U105348. URL: https://medinstytut.lviv.ua/wp-content/uploads/pdf/Dovidka-pro-zatverdzhennya-temy-LMI.pdf.
Shapovalova V., Shapovalov V., Osyntseva A. et al. Organization of the pharmaceutical business, industrial pharmacy and forensic pharmacy concerning the competences of quality management during the circulation of medical products: GxP standards. Actual problems of medicine and pharmacy. 2022. Vol.3. N. 2. P.1–20. URL: https://doi.org/10.52914/apmp.v3i2.44. DOI: https://doi.org/10.52914/apmp.v3i2.44
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2024 Viktoriia Shapovalova
This work is licensed under a Creative Commons Attribution 4.0 International License.
